BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12846495)

  • 41. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
    Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
    Cancer; 1998 Nov; 83(10):2083-90. PubMed ID: 9827712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study.
    Thomas P; Castelnau O; Paillotin D; Léna H; Robinet G; Muir JF; Delaval P; Gouva S; Balmes P; Blanchon F; Perdu D; Poirier R; Pommier De Santi P; Penot-Ragon C; Kleisbauer JP
    J Clin Oncol; 2001 Mar; 19(5):1320-5. PubMed ID: 11230474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332.
    Johnson E; Lake D; Herndon JE; Box JW; Lynch TJ; Green MR
    Am J Clin Oncol; 2004 Feb; 27(1):19-23. PubMed ID: 14758128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).
    Laack E; Thöm I; Krüll A; Engel-Riedel W; Müller T; Meissner C; Dürk H; Fischer J; Gütz S; Kortsik C; Elbers M; Schuch G; Andritzky B; Görn M; Burkholder I; Edler L; Hossfeld DK; Bokemeyer C
    Lung Cancer; 2007 Aug; 57(2):181-6. PubMed ID: 17442447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
    J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer.
    Jacoulet P; Breton JL; Westeel V; Mercier M; Garnier G; Depierre A
    Lung Cancer; 1995 Jun; 12(3):247-57. PubMed ID: 7655834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status.
    Koussis H; Scola A; Bergamo F; Tonello S; Basso U; Karahontzitis P; Chiarion-Sileni V; Pasetto L; Ruol A; Loreggian L; Lora O; Bottin R; Marioni G; Donach M; Jirillo A
    Anticancer Res; 2008; 28(2B):1383-8. PubMed ID: 18505084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide.
    Jones AL; Holborn J; Ashley S; Smith IE
    Eur J Cancer; 1991; 27(7):866-70. PubMed ID: 1657078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
    Hesketh PJ; McCoy J; Dunphy FR; Bearden JD; Weiss GR; Giguere JK; Atkins JN; Dakhil SR; Kelly K; Crowley JJ; Gandara DR
    J Thorac Oncol; 2006 Nov; 1(9):991-5. PubMed ID: 17409984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.
    Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
    J Natl Cancer Inst; 2003 Aug; 95(15):1118-27. PubMed ID: 12902441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer.
    Sohn JH; Choi HJ; Chang J; Kim SK; Lee CG; Chung KY; Kim DJ; Cho BC; Shin SJ; Moon YW; Kim JH
    Lung Cancer; 2006 Dec; 54(3):365-70. PubMed ID: 17011068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).
    Patel SH; Ajlouni M; Chapman R; Lu M; Movsas B; Kim JH
    J Thorac Oncol; 2007 Sep; 2(9):831-7. PubMed ID: 17805061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
    Liu D; Zheng X; Chen J; Liu G; Xu Y; Shen Y; Xie L; Zhao W; Jiang G; Fan M
    Lung Cancer; 2015 Sep; 89(3):249-54. PubMed ID: 26118463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carboplatin and vinorelbine in advanced non-small cell lung cancer: a phase I/II study.
    Masters G
    Oncologist; 2001; 6 Suppl 1():12-5. PubMed ID: 11181999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.
    Inoue A; Yamazaki K; Maemondo M; Suzuki T; Kimura Y; Kanbe M; Isobe H; Nishimura M; Saijo Y; Nukiwa T
    J Thorac Oncol; 2006 Jul; 1(6):551-5. PubMed ID: 17409916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
    Bennouna J; Havel L; Krzakowski M; Kollmeier J; Gervais R; Dansin E; Serke M; Favaretto A; Szczesna A; Cobo M; Ciuffreda L; Jassem J; Nicolini M; Ramlau R; Amoroso D; Melotti B; Almodovar T; Riggi M; Caux NR; Vaissière N; Tan EH
    Clin Lung Cancer; 2014 Jul; 15(4):258-65. PubMed ID: 24954228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.
    Higano CS; Crowley JJ; Veith RV; Livingston RB
    Invest New Drugs; 1997; 15(2):153-6. PubMed ID: 9220295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and toxicity of vinorelbine-carboplatin combination in the treatment of advanced adenocarcinoma or large-cell carcinoma of the lung.
    Masotti A; Borzellino G; Zannini G; Laterza E; Ricci F; Morandini G
    Tumori; 1995; 81(2):112-6. PubMed ID: 7539964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer.
    Michel G; Leyvraz S; Bauer J; Aapro M; Stahel R; Alberto P
    Ann Oncol; 1994 Apr; 5(4):369-70. PubMed ID: 8075036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vinorelbine and carboplatin-induced black tongue: A case report.
    Sow ML; Moukafih B; Balde S; Elkhoyaali S; Chaibi A; Abahssain H; Mrabti H; Errihani H
    Therapie; 2020; 75(3):297-301. PubMed ID: 31477338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.